Actively Recruiting
In Vivo Real-time Detection of Circulating Melanoma Cells
Led by University of Arkansas · Updated on 2025-07-16
75
Participants Needed
1
Research Sites
699 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.
CONDITIONS
Official Title
In Vivo Real-time Detection of Circulating Melanoma Cells
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 80 years
- Histological documented diagnosis of melanoma
- Signed informed consent form approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB)
- Must be able to sit still for 90 minutes
You will not qualify if you...
- Active infection
- Current and significant medical or surgical condition as determined by the Investigator
- Diagnosis or evidence of organic brain syndrome
- Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205
Actively Recruiting
Research Team
J
Jumin Sunde, MD
CONTACT
D
Daniel Dunham
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here